Parse Biosciences raises $41.5M Series B round to scale single-cell sequencing products and expand product portfolio
Parse Biosciences, a company dedicated to providing scalable single-cell sequencing solutions, today announced $41.5M in Series B funding co-led by Marshall ...
Source: antaranews.com